Globus Medical (GMED) EPS (Basic) (2011 - 2026)

Globus Medical has reported EPS (Basic) for 16 years, with the latest figure at $0.92 in Q1 2026.

• For the quarter ending Q1 2026, EPS (Basic) rose 67.27% year-over-year to $0.92; the trailing twelve-month figure through Mar 2026 stood at $4.35 (up 219.85% YoY), and the FY2025 full-year result was $3.98, up 423.68% from the prior year.
• EPS (Basic) for Q1 2026 stood at $0.92, down from $1.05 in the prior quarter.
• The five-year high for EPS (Basic) was $1.5 in Q2 2025, with the low at -$0.05 in Q1 2024.
• Historically, EPS (Basic) has averaged $0.51 across 5 years, with a median of $0.49 in 2023.
• The largest YoY upside for EPS (Basic) was 3700.0% in 2024 against a maximum downside of 110.2% in 2024.
• Globus Medical's EPS (Basic) stood at $0.5 in 2022, then sank by 88.0% to $0.06 in 2023, then surged by 233.33% to $0.2 in 2024, then surged by 425.0% to $1.05 in 2025, then declined by 12.38% to $0.92 in 2026.
• The last three EPS (Basic) figures came in at $0.92 (Q1 2026), $1.05 (Q4 2025), and $0.88 (Q3 2025), per Business Quant data.